In the following you can listen to an interview with Prof. Christopher Chapple, Secretary General of EAU (European Association of Urology) on best quality of care and co-operation of clinicians and patient organisations.
The Committee for Medicinal Products for Human Use (CHMP), part of the European Medicines Agency, has handed down a negative opinion on the approval of combination ipilimumab and nivolumab for the frontline treatment of advanced renal cell carcinoma. The main [...]
VHLFA Greece has been doing some pretty amazing work in putting von Hippel-Lindau and kidney cancer on the map! With the help of Perceptions Consulting (www.perception.com.gr) they organized a press conference at Divani Caravel, a large central hotel in Athens, [...]
by Susan Poteat and Hans Hammers, M.D. KCCure is pleased to announce an inaugural Request for Applications for a $100,000 Grant Award to fund innovative high-risk, high-impact ideas for kidney cancer research. The application deadline is March 15, 2017. The [...]
Two Canadians diagnosed with kidney cancer who filled a gap in the Canadian health care system received Meritorious Service Decorations June 23, 2016, from Canada's Governor General David Johnston at a ceremony in Ottawa. Deb Maskens and the late Tony Clark, [...]